Risk-benefit assessment of oral phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction: A multiple criteria decision analysis

J. C. Hsu, D. H. Tang, C. Y. Lu

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Risk-benefit assessment of oral phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction: A multiple criteria decision analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences